Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 681

1.

Editorial overview.

Tack J, Sarnelli G.

Curr Opin Pharmacol. 2018 Dec;43:vi-vii. doi: 10.1016/j.coph.2018.11.005. Epub 2018 Nov 24. No abstract available.

PMID:
30482447
2.

High-resolution impedance manometry parameters in the evaluation of esophageal function of non-obstructive dysphagia patients.

Singendonk MJ, Lin Z, Scheerens C, Tack J, Carlson DA, Omari TI, Pandolfino JE, Rommel N.

Neurogastroenterol Motil. 2018 Nov 13:e13505. doi: 10.1111/nmo.13505. [Epub ahead of print]

PMID:
30426609
3.

How Effective Are Secretagogues for Irritable Bowel Syndrome With Constipation.

Pannemans J, Tack J.

Gastroenterology. 2018 Dec;155(6):1677-1679. doi: 10.1053/j.gastro.2018.11.005. Epub 2018 Nov 9. No abstract available.

PMID:
30419211
4.

Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method.

Smeets FGM, Keszthelyi D, Vork L, Tack J, Talley NJ, Simren M, Aziz Q, Ford AC, Conchillo JM, Kruimel JW, Van Os J, Masclee AAM.

Neurogastroenterol Motil. 2018 Nov 4:e13496. doi: 10.1111/nmo.13496. [Epub ahead of print]

PMID:
30393939
5.

Altered duodenal bile salt concentration and receptor expression in functional dyspepsia.

Beeckmans D, Riethorst D, Augustijns P, Vanuytsel T, Farré R, Tack J, Vanheel H.

United European Gastroenterol J. 2018 Nov;6(9):1347-1355. doi: 10.1177/2050640618799120. Epub 2018 Sep 4.

6.

Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis.

Ang D, Zheng Q, Shi L, Tack J.

United European Gastroenterol J. 2018 Nov;6(9):1294-1306. doi: 10.1177/2050640618772787. Epub 2018 Apr 20. Review.

7.

Reply.

Clevers E, Whitehead WE, Palsson OS, Sperber AD, Törnblom H, Van Oudenhove L, Tack J, Simrén M.

Clin Gastroenterol Hepatol. 2018 Oct 10. pii: S1542-3565(18)31092-9. doi: 10.1016/j.cgh.2018.10.009. [Epub ahead of print] No abstract available.

PMID:
30315945
8.

New developments in the treatment of opioid-induced gastrointestinal symptoms.

Pannemans J, Vanuytsel T, Tack J.

United European Gastroenterol J. 2018 Oct;6(8):1126-1135. doi: 10.1177/2050640618796748. Epub 2018 Aug 27. Review.

9.

The circadian clock regulates the diurnal levels of microbial short-chain fatty acids and their rhythmic effects on colon contractility in mice.

Segers A, Desmet L, Thijs T, Verbeke K, Tack J, Depoortere I.

Acta Physiol (Oxf). 2018 Sep 30:e13193. doi: 10.1111/apha.13193. [Epub ahead of print]

PMID:
30269420
10.

The optimal order of stimulation modalities and reproducibility of the multimodal esophageal stimulation paradigm.

Broers C, Boecxstaens V, Deloose E, Tack J, Pauwels A.

Neurogastroenterol Motil. 2018 Sep 23:e13475. doi: 10.1111/nmo.13475. [Epub ahead of print]

PMID:
30246470
11.

New developments in the treatment of gastroparesis and functional dyspepsia.

Tack J, Camilleri M.

Curr Opin Pharmacol. 2018 Dec;43:111-117. doi: 10.1016/j.coph.2018.08.015. Epub 2018 Sep 21. Review.

PMID:
30245474
12.

Gastroduodenal motility disorders.

Tack J, Van den Houte K, Carbone F.

Curr Opin Gastroenterol. 2018 Nov;34(6):428-435. doi: 10.1097/MOG.0000000000000473.

PMID:
30199408
13.

The 2018 ISDE achalasia guidelines.

Zaninotto G, Bennett C, Boeckxstaens G, Costantini M, Ferguson MK, Pandolfino JE, Patti MG, Ribeiro U Jr, Richter J, Swanstrom L, Tack J, Triadafilopoulos G, Markar SR, Salvador R, Faccio L, Andreollo NA, Cecconello I, Costamagna G, da Rocha JRM, Hungness ES, Fisichella PM, Fuchs KH, Gockel I, Gurski R, Gyawali CP, Herbella FAM, Holloway RH, Hongo M, Jobe BA, Kahrilas PJ, Katzka DA, Dua KS, Liu D, Moonen A, Nasi A, Pasricha PJ, Penagini R, Perretta S, Sallum RAA, Sarnelli G, Savarino E, Schlottmann F, Sifrim D, Soper N, Tatum RP, Vaezi MF, van Herwaarden-Lindeboom M, Vanuytsel T, Vela MF, Watson DI, Zerbib F, Gittens S, Pontillo C, Vermigli S, Inama D, Low DE.

Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy071.

PMID:
30169645
14.

A comparison of various intragastric balloons for the assessment of gastric motility.

Janssen P, Goelen N, Tack J.

Neurogastroenterol Motil. 2018 Dec;30(12):e13453. doi: 10.1111/nmo.13453. Epub 2018 Aug 23.

PMID:
30136334
15.

The effect of sildenafil on gastric motility and satiation in healthy controls.

Carbone F, Tack J.

United European Gastroenterol J. 2018 Jul;6(6):846-854. doi: 10.1177/2050640618766933. Epub 2018 Mar 30.

16.

New treatments and therapeutic targets for IBS and other functional bowel disorders.

Simrén M, Tack J.

Nat Rev Gastroenterol Hepatol. 2018 Oct;15(10):589-605. doi: 10.1038/s41575-018-0034-5. Review.

PMID:
29930260
17.

A reduced esophageal epithelial integrity in a subgroup of healthy individuals increases with proton pump inhibitor therapy.

Pauwels A, Broers C, Vanuytsel T, Pardon N, Cocca S, Roman S, Zerbib F, Tack J, Farré R.

United European Gastroenterol J. 2018 May;6(4):511-518. doi: 10.1177/2050640617749115. Epub 2017 Dec 17.

18.

New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases.

Bajaj JS, Barbara G, DuPont HL, Mearin F, Gasbarrini A, Tack J.

Dig Liver Dis. 2018 Aug;50(8):741-749. doi: 10.1016/j.dld.2018.04.020. Epub 2018 Apr 27. Review.

PMID:
29807873
19.

Human intestinal fluid layer separation: The effect on colloidal structures & solubility of lipophilic compounds.

Riethorst D, Mitra A, Kesisoglou F, Xu W, Tack J, Brouwers J, Augustijns P.

Eur J Pharm Biopharm. 2018 Aug;129:104-110. doi: 10.1016/j.ejpb.2018.05.026. Epub 2018 May 24.

PMID:
29802985
20.

Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers.

Chalet C, Rubbens J, Tack J, Duchateau GS, Augustijns P.

J Pharm Pharmacol. 2018 Aug;70(8):1002-1008. doi: 10.1111/jphp.12929. Epub 2018 May 15.

PMID:
29761870

Supplemental Content

Loading ...
Support Center